Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Continuation of an atypical antipsychotic medication in combination with a Mood
Stabilizer, following remission from an acute manic episode, lowers the rates of relapse and
recurrence of mood episodes compared to discontinuing the antipsychotics within days of
resolution of manic symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
University of British Columbia
Collaborators:
Canadian Institutes of Health Research (CIHR) Eli Lilly and Company Janssen-Ortho Inc., Canada